Bioventus Inc (BVS)
6.37
-0.26
(-3.92%)
USD |
NASDAQ |
May 17, 16:00
6.37
0.00 (0.00%)
After-Hours: 20:00
Bioventus Shareholders Equity (Quarterly): 171.28M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 171.28M |
December 31, 2023 | 173.59M |
September 30, 2023 | 177.53M |
June 30, 2023 | 183.20M |
March 31, 2023 | 188.51M |
December 31, 2022 | 325.24M |
September 30, 2022 | 343.40M |
June 30, 2022 | 447.98M |
March 31, 2022 | 449.78M |
Date | Value |
---|---|
December 31, 2021 | 458.92M |
September 30, 2021 | 152.50M |
June 30, 2021 | 141.56M |
March 31, 2021 | 142.39M |
December 31, 2020 | 144.16M |
September 30, 2020 | 143.22M |
December 31, 2019 | 142.98M |
March 31, 2016 | 186.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
141.56M
Minimum
Jun 2021
458.92M
Maximum
Dec 2021
236.64M
Average
175.56M
Median
Shareholders Equity (Quarterly) Benchmarks
Perspective Therapeutics Inc | 229.89M |
Retractable Technologies Inc | 99.29M |
Xtant Medical Holdings Inc | 47.68M |
Asensus Surgical Inc | 13.02M |
Catheter Precision Inc | 18.52M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 794.24M |
Total Liabilities (Quarterly) | 576.81M |
Debt to Equity Ratio | 2.284 |
Current Ratio | 1.534 |
Net Debt Paydown Yield | 1.62% |